Adult
131
27
29
59
Key Insights
Highlights
Success Rate
84% trial completion
Research Maturity
59 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.4%
11 terminated out of 131 trials
84.3%
-2.3% vs benchmark
5%
6 trials in Phase 3/4
5%
3 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 59 completed trials
Clinical Trials (131)
Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury
Cognitive Neuroscience of Autism Spectrum Disorders
Long-term Follow-up of Subjects Treated With CAR T Cells
Study of New Magnetic Resonance Imaging Methods of the Brain
Probiotic Research: Open-label Functional Intervention and Longitudinal Evaluation in Healthy Adults
Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital.
A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults
Peanuts for Cardiometabolic, Brain, and Intestinal Health
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
Experience and Understanding of the Mouth, Oral Health and Function Amongst Adults With Disabilities and Complex Health Conditions.
The Effects of Endotracheal Suctioning on Pain and Serum Markers
A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Hydroponic vs Conventional Spinach Smoothies: Effects on Salivary Nitrate Bioavailability and Blood Pressure
Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
The Impact of Hunova® Robotic Platform Rehabilitation
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)